Nirupa Sachithanandan

828 total citations
37 papers, 567 citations indexed

About

Nirupa Sachithanandan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Nirupa Sachithanandan has authored 37 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 11 papers in Oncology. Recurrent topics in Nirupa Sachithanandan's work include Adrenal and Paraganglionic Tumors (11 papers), Neuroendocrine Tumor Research Advances (7 papers) and Adrenal Hormones and Disorders (7 papers). Nirupa Sachithanandan is often cited by papers focused on Adrenal and Paraganglionic Tumors (11 papers), Neuroendocrine Tumor Research Advances (7 papers) and Adrenal Hormones and Disorders (7 papers). Nirupa Sachithanandan collaborates with scholars based in Australia, United States and Canada. Nirupa Sachithanandan's co-authors include Thomas W. H. Kay, Gregory R. Steinberg, Sandra Galić, John Burgess, Stacey Fynch, Jane Honeyman, Richard J. MacIsaac, Kimberly Hewitt, Kate L. Graham and David N. O’Neal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Nirupa Sachithanandan

32 papers receiving 557 citations

Peers

Nirupa Sachithanandan
Georgios Kyriakopoulos Greece
Norito Yagihashi Japan
Mengsu Zeng China
Ryota Kawase Japan
Yukihiro Nagai Japan
Nobuhiko Wada Japan
Guangda Xiang China
A Raisonnier France
Katherine D. Hein United States
Miyako Yuasa‐Kawase Japan
Georgios Kyriakopoulos Greece
Nirupa Sachithanandan
Citations per year, relative to Nirupa Sachithanandan Nirupa Sachithanandan (= 1×) peers Georgios Kyriakopoulos

Countries citing papers authored by Nirupa Sachithanandan

Since Specialization
Citations

This map shows the geographic impact of Nirupa Sachithanandan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirupa Sachithanandan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirupa Sachithanandan more than expected).

Fields of papers citing papers by Nirupa Sachithanandan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirupa Sachithanandan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirupa Sachithanandan. The network helps show where Nirupa Sachithanandan may publish in the future.

Co-authorship network of co-authors of Nirupa Sachithanandan

This figure shows the co-authorship network connecting the top 25 collaborators of Nirupa Sachithanandan. A scholar is included among the top collaborators of Nirupa Sachithanandan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirupa Sachithanandan. Nirupa Sachithanandan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pattison, David A., Grace Kong, Timothy Akhurst, et al.. (2025). Peptide receptor radionuclide therapy in malignant insulinoma. Endocrine Related Cancer. 32(6).
2.
3.
Preston, C., et al.. (2024). Utility of Adrenal Vein Sampling With and Without Ultra‐Low Dose ACTH Infusion in the Diagnostic Evaluation of Primary Aldosteronism. Endocrinology Diabetes & Metabolism. 7(5). e70001–e70001. 2 indexed citations
4.
Preston, C., et al.. (2024). Insulinoma: Metastatic Recurrence 38 Years Following Initial Diagnosis in Pregnancy. JCEM Case Reports. 2(2). luad168–luad168. 1 indexed citations
5.
6.
Boehm, Emma, Tim Akhurst, Ramin Alipour, et al.. (2024). Peptide receptor radionuclide therapy for ectopic Cushing’s syndrome caused by metastatic neuroendocrine neoplasms. SHILAP Revista de lepidopterología. 4(1). e240013–e240013.
7.
Sachithanandan, Nirupa, et al.. (2023). Glucagon‐like peptide‐1 receptor agonists in the perioperative period: to cease or not to cease?. ANZ Journal of Surgery. 94(4). 510–512. 2 indexed citations
8.
Wallace, Roslyn, Balasubramanian Krishnamurthy, Thomas W. H. Kay, et al.. (2023). Increased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis. Cancers. 15(24). 5803–5803. 7 indexed citations
9.
Iravani, Amir, Arian Lasocki, Roslyn Wallace, et al.. (2023). Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis. Frontiers in Endocrinology. 14. 1295865–1295865. 4 indexed citations
10.
Januszewski, Andrzej S., Nirupa Sachithanandan, Glenn M. Ward, et al.. (2022). Independent euglycaemic hyperinsulinaemic clamp studies validate clinically applicable formulae to estimate insulin sensitivity in people with type 1 diabetes. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(1). 102691–102691. 2 indexed citations
11.
Farrell, Stephen, et al.. (2021). Utility of semi‐quantitative quick cortisol assay with low‐dose adrenocorticotropic hormone infusion adrenal vein sampling. ANZ Journal of Surgery. 92(3). 437–442. 5 indexed citations
12.
Januszewski, Andrzej S., Nirupa Sachithanandan, Glenn M. Ward, et al.. (2020). Estimated insulin sensitivity in Type 1 diabetes adults using clinical and research biomarkers. Diabetes Research and Clinical Practice. 167. 108359–108359. 14 indexed citations
13.
Ward, Glenn M., et al.. (2020). Insulin Autoimmune Syndrome: A Case of Clopidogrel-induced Autoimmune Hypoglycemia. The Journal of Clinical Endocrinology & Metabolism. 105(4). 996–999. 8 indexed citations
14.
Iravani, Amir, Arian Lasocki, Roslyn Wallace, et al.. (2020). SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations
15.
MacIsaac, Richard J., et al.. (2016). Decrease in serum potassium levels post saline suppression test in primary aldosteronism: an under-recognised phenomenon?. Journal of Human Hypertension. 30(11). 664–665. 4 indexed citations
16.
Abell, Sally K., et al.. (2015). Prolonged life-threatening hypoglycaemia following dose escalation of octreotide LAR in a patient with malignant polysecreting pancreatic neuroendocrine tumour. Endocrinology Diabetes and Metabolism Case Reports. 2015. 140097–140097. 10 indexed citations
17.
Sachithanandan, Nirupa, Kate L. Graham, Sandra Galić, et al.. (2011). Macrophage Deletion of SOCS1 Increases Sensitivity to LPS and Palmitic Acid and Results in Systemic Inflammation and Hepatic Insulin Resistance. Diabetes. 60(8). 2023–2031. 70 indexed citations
18.
Sachithanandan, Nirupa, Barbara C. Fam, Stacey Fynch, et al.. (2010). Liver-Specific Suppressor of Cytokine Signaling-3 Deletion in Mice Enhances Hepatic Insulin Sensitivity and Lipogenesis Resulting in Fatty Liver and Obesity. Hepatology. 52(5). 1632–1642. 90 indexed citations
19.
Sachithanandan, Nirupa, et al.. (2004). Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1. Cancer. 103(3). 509–515. 101 indexed citations
20.
Liang, Yu‐Lu, Helena Teede, Louise Shiel, et al.. (1997). EFFECTS OF OESTROGEN AND PROGESTERONE ON AGE‐RELATED CHANGES IN ARTERIES OF POSTMENOPAUSAL WOMEN. Clinical and Experimental Pharmacology and Physiology. 24(6). 457–459. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgios Kyriakopoulos Breakdown of academic impact, for papers by Norito Yagihashi Breakdown of academic impact, for papers by Mengsu Zeng Breakdown of academic impact, for papers by Ryota Kawase Breakdown of academic impact, for papers by Yukihiro Nagai Breakdown of academic impact, for papers by Nobuhiko Wada Breakdown of academic impact, for papers by Guangda Xiang Breakdown of academic impact, for papers by A Raisonnier Breakdown of academic impact, for papers by Katherine D. Hein Breakdown of academic impact, for papers by Miyako Yuasa‐Kawase
Rankless by CCL
2026